Endothelial TNF Receptor 2 Induces IRF1 Transcription Factor-Dependent Interferon-β Autocrine Signaling to Promote Monocyte Recruitment

Immunity

Volumn 38, Issue 5, 2013, Pages 1025-1037

  Venkatesh, Deepak ^a   Ernandez, Thomas ^a   Rosetti, Florencia ^a,b   Batal, Ibrahim ^a   Cullere, Xavier ^a   Luscinskas, FrancisW ^a   Zhang, Yuzhi ^a   Stavrakis, George ^a   García Cardeña, Guillermo ^a   Horwitz, BruceH ^a   Mayadas, TanyaN ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CHEMOKINE RECEPTOR CXCR3; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON REGULATORY FACTOR 1; MX1 PROTEIN; PROTEIN; STAT1 PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL STIMULATION; CELL TRANSPORT; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MICROVASCULATURE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; AUTOCRINE COMMUNICATION; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTOR-1; INTERFERON-BETA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NEPHRITIS; NEUTROPHILS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, CXCR3; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; STAT1 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878192561     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.01.012     Document Type: Article

References (50)

1. Akassoglou K., Douni E., Bauer J., Lassmann H., Kollias G., Probert L. Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice. Proc. Natl. Acad. Sci. USA 2003, 100:709-714.
2. Al-Lamki R.S., Wang J., Skepper J.N., Thiru S., Pober J.S., Bradley J.R. Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab. Invest. 2001, 81:1503-1515.
3. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J.Exp. Med. 2003, 197:711-723.
4. Bossen C., Ingold K., Tardivel A., Bodmer J.L., Gaide O., Hertig S., Ambrose C., Tschopp J., Schneider P. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J.Biol. Chem. 2006, 281:13964-13971.
5. Bradley J.R. TNF-mediated inflammatory disease. J.Pathol. 2008, 214:149-160.
6. Bruggeman L.A., Drawz P.E., Kahoud N., Lin K., Barisoni L., Nelson P.J. TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α. Lab. Invest. 2011, 91:413-425.
7. Cinamon G., Shinder V., Alon R. Shear forces promote lymphocyte migration across vascular endothelium bearing apical chemokines. Nat. Immunol. 2001, 2:515-522.
8. Comabella M., Lünemann J.D., Río J., Sánchez A., López C., Julià E., Fernández M., Nonell L., Camiña-Tato M., Deisenhammer F., et al. A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain 2009, 132:3353-3365.
9. Decker T., Müller M., Stockinger S. The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 2005, 5:675-687.
10. Douni E., Kollias G. A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R. J.Exp. Med. 1998, 188:1343-1352.
11. Doyle S., Vaidya S., O'Connell R., Dadgostar H., Dempsey P., Wu T., Rao G., Sun R., Haberland M., Modlin R., Cheng G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002, 17:251-263.
12. Ernandez T., Mayadas T.N. Immunoregulatory role of TNFalpha in inflammatory kidney diseases. Kidney Int. 2009, 76:262-276.
13. Fairhurst A.M., Xie C., Fu Y., Wang A., Boudreaux C., Zhou X.J., Cibotti R., Coyle A., Connolly J.E., Wakeland E.K., Mohan C. Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis. J.Immunol. 2009, 183:6831-6838.
14. Fujita T., Reis L.F., Watanabe N., Kimura Y., Taniguchi T., Vilcek J. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA 1989, 86:9936-9940.
15. Gaeta M.L., Johnson D.R., Kluger M.S., Pober J.S. The death domain of tumor necrosis factor receptor 1 is necessary but not sufficient for Golgi retention of the receptor and mediates receptor desensitization. Lab. Invest. 2000, 80:1185-1194.
16. Grell M., Douni E., Wajant H., Löhden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80kDa tumor necrosis factor receptor. Cell 1995, 83:793-802.
17. Hillyer P., Mordelet E., Flynn G., Male D. Chemokines, chemokine receptors and adhesion molecules on different human endothelia: discriminating the tissue-specific functions that affect leucocyte migration. Clin. Exp. Immunol. 2003, 134:431-441.
18. Hoffmann U., Bergler T., Rihm M., Pace C., Kruger B., Rummele P., Stoelcker B., Banas B., Mannel D.N., Kramer B.K. Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am. J. Transplant. 2009, 9:675-686.
19. Honda K., Takaoka A., Taniguchi T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006, 25:349-360.
20. Huys L., Van Hauwermeiren F., Dejager L., Dejonckheere E., Lienenklaus S., Weiss S., Leclercq G., Libert C. Type I interferon drives tumor necrosis factor-induced lethal shock. J.Exp. Med. 2009, 206:1873-1882.
21. Katschke K.J., Rottman J.B., Ruth J.H., Qin S., Wu L., LaRosa G., Ponath P., Park C.C., Pope R.M., Koch A.E. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 2001, 44:1022-1032.
22. Kuldo J.M., Westra J., Asgeirsdóttir S.A., Kok R.J., Oosterhuis K., Rots M.G., Schouten J.P., Limburg P.C., Molema G. Differential effects of NF-kappaB and p38 MAPK inhibitors and combinations thereof on TNF-alpha- and IL-1beta-induced proinflammatory status of endothelial cells invitro. Am. J. Physiol. Cell Physiol. 2005, 289:C1229-C1239.
23. Lacotte S., Brun S., Muller S., Dumortier H. CXCR3, inflammation, and autoimmune diseases. Ann. N Y Acad. Sci. 2009, 1173:310-317.
24. Leeuwenberg J.F., van Damme J., Jeunhomme G.M., Buurman W.A. Interferon beta 1, an intermediate in the tumor necrosis factor alpha-induced increased MHC class I expression and an autocrine regulator of the constitutive MHC class I expression. J.Exp. Med. 1987, 166:1180-1185.
25. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
26. Lucas R., Juillard P., Decoster E., Redard M., Burger D., Donati Y., Giroud C., Monso-Hinard C., De Kesel T., Buurman W.A., et al. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 1997, 27:1719-1725.
27. Luscinskas F.W., Ding H., Tan P., Cumming D., Tedder T.F., Gerritsen M.E. L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-alpha-activated vascular endothelium under flow invitro. J.Immunol. 1996, 157:326-335.
28. Luster A.D., Alon R., von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 2005, 6:1182-1190.
29. MacEwan D.J. TNF ligands and receptors-a matter of life and death. Br. J. Pharmacol. 2002, 135:855-875.
30. Ohmori Y., Wyner L., Narumi S., Armstrong D., Stoler M., Hamilton T.A. Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines invivo. Am. J. Pathol. 1993, 142:861-870.
31. Piali L., Weber C., LaRosa G., Mackay C.R., Springer T.A., Clark-Lewis I., Moser B. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur. J. Immunol. 1998, 28:961-972.
32. Sakaguchi S., Negishi H., Asagiri M., Nakajima C., Mizutani T., Takaoka A., Honda K., Taniguchi T. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem. Biophys. Res. Commun. 2003, 306:860-866.
33. Santee S.M., Owen-Schaub L.B. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J.Biol. Chem. 1996, 271:21151-21159.
34. Satchell S.C., Buchatska O., Khan S.B., Bhangal G., Tasman C.H., Saleem M.A., Baker D.P., Lobb R.R., Smith J., Cook H.T., et al. Interferon-beta reduces proteinuria in experimental glomerulonephritis. J.Am. Soc. Nephrol. 2007, 18:2875-2884.
35. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300:1148-1151.
36. Taub D.D., Lloyd A.R., Conlon K., Wang J.M., Ortaldo J.R., Harada A., Matsushima K., Kelvin D.J., Oppenheim J.J. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes Tcell adhesion to endothelial cells. J.Exp. Med. 1993, 177:1809-1814.
37. Taub D.D., Longo D.L., Murphy W.J. Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID mice. Blood 1996, 87:1423-1431.
38. Theofilopoulos A.N., Baccala R., Beutler B., Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005, 23:307-336.
39. Timoshanko J.R., Sedgwick J.D., Holdsworth S.R., Tipping P.G. Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J.Am. Soc. Nephrol. 2003, 14:1785-1793.
40. Tliba O., Tliba S., Da Huang C., Hoffman R.K., DeLong P., Panettieri R.A., Amrani Y. Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta. J.Biol. Chem. 2003, 278:50615-50623.
41. Tsuboi N., Asano K., Lauterbach M., Mayadas T.N. Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 2008, 28:833-846.
42. van der Pouw Kraan T.C., Wijbrandts C.A., van Baarsen L.G., Voskuyl A.E., Rustenburg F., Baggen J.M., Ibrahim S.M., Fero M., Dijkmans B.A., Tak P.P., Verweij C.L. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann. Rheum. Dis. 2007, 66:1008-1014.
43. Vassalli P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 1992, 10:411-452.
44. Vielhauer V., Mayadas T.N. Functions of TNF and its receptors in renal disease: distinct roles in inflammatory tissue injury and immune regulation. Semin. Nephrol. 2007, 27:286-308.
45. Vielhauer V., Stavrakis G., Mayadas T.N. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J.Clin. Invest. 2005, 115:1199-1209.
46. Wright H.L., Chikura B., Bucknall R.C., Moots R.J., Edwards S.W. Changes in expression of membrane TNF, NF-kappaB activation and neutrophil apoptosis during active and resolved inflammation. Ann. Rheum. Dis. 2011, 70:537-543.
47. Xie J.H., Nomura N., Lu M., Chen S.L., Koch G.E., Weng Y., Rosa R., Di Salvo J., Mudgett J., Peterson L.B., et al. Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation. J.Leukoc. Biol. 2003, 73:771-780.
48. Yao Y., Richman L., Morehouse C., de los Reyes M., Higgs B.W., Boutrin A., White B., Coyle A., Krueger J., Kiener P.A., Jallal B. Type I interferon: potential therapeutic target for psoriasis?. PLoS ONE 2008, 3:e2737.
49. Yarilina A., Park-Min K.H., Antoniv T., Hu X., Ivashkiv L.B. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat. Immunol. 2008, 9:378-387.
50. Zhou J., Tang P.C., Qin L., Gayed P.M., Li W., Skokos E.A., Kyriakides T.R., Pober J.S., Tellides G. CXCR3-dependent accumulationandactivation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses. J.Exp. Med. 2010, 207:1951-1966.